247 related articles for article (PubMed ID: 23210785)
1. From resveratrol to its derivatives: new sources of natural antioxidant.
He S; Yan X
Curr Med Chem; 2013; 20(8):1005-17. PubMed ID: 23210785
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and stroke: from chemistry to medicine.
Nabavi SF; Li H; Daglia M; Nabavi SM
Curr Neurovasc Res; 2014; 11(4):390-7. PubMed ID: 25219659
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Versatility of Resveratrol Derivatives.
Nawaz W; Zhou Z; Deng S; Ma X; Ma X; Li C; Shu X
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29109374
[TBL] [Abstract][Full Text] [Related]
4. Derivatives of resveratrol: potential agents in prevention and treatment of cardiovascular disease.
Ruan BF; Lu XQ; Song J; Zhu HL
Curr Med Chem; 2012; 19(24):4175-83. PubMed ID: 22830334
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship studies of resveratrol and its analogues by the reaction kinetics of low density lipoprotein peroxidation.
Cheng JC; Fang JG; Chen WF; Zhou B; Yang L; Liu ZL
Bioorg Chem; 2006 Jun; 34(3):142-57. PubMed ID: 16712899
[TBL] [Abstract][Full Text] [Related]
6. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Heynekamp JJ; Weber WM; Hunsaker LA; Gonzales AM; Orlando RA; Deck LM; Jagt DL
J Med Chem; 2006 Nov; 49(24):7182-9. PubMed ID: 17125270
[TBL] [Abstract][Full Text] [Related]
7. The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential.
Kroon PA; Iyer A; Chunduri P; Chan V; Brown L
Curr Med Chem; 2010; 17(23):2442-55. PubMed ID: 20491649
[TBL] [Abstract][Full Text] [Related]
8. Aza- and Azo-Stilbenes: Bio-Isosteric Analogs of Resveratrol.
Lizard G; Latruffe N; Vervandier-Fasseur D
Molecules; 2020 Jan; 25(3):. PubMed ID: 32019195
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of resveratrol in Alzheimer's disease.
Vingtdeux V; Dreses-Werringloer U; Zhao H; Davies P; Marambaud P
BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S6. PubMed ID: 19090994
[TBL] [Abstract][Full Text] [Related]
10. A scalable biomimetic synthesis of resveratrol dimers and systematic evaluation of their antioxidant activities.
Matsuura BS; Keylor MH; Li B; Lin Y; Allison S; Pratt DA; Stephenson CR
Angew Chem Int Ed Engl; 2015 Mar; 54(12):3754-7. PubMed ID: 25650836
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activities and structure-modification of resveratrol analogues.
Xiao Y; Chen H; Song C; Zeng X; Zheng Q; Zhang Y; Lei X; Zheng X
Pharmazie; 2015 Dec; 70(12):765-71. PubMed ID: 26817272
[TBL] [Abstract][Full Text] [Related]
12. 4,4'-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity.
Fan GJ; Liu XD; Qian YP; Shang YJ; Li XZ; Dai F; Fang JG; Jin XL; Zhou B
Bioorg Med Chem; 2009 Mar; 17(6):2360-5. PubMed ID: 19251420
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic and Antioxidant Activities of Imine Analogs of Trans-Resveratrol towards Murine Neuronal N2a Cells.
Ksila M; Vejux A; Prost-Camus E; Durand P; Ghzaiel I; Nury T; Duprey D; Meziane S; Masmoudi-Kouki O; Latruffe N; Ghrairi T; Prost M; Lizard G; Vervandier-Fasseur D
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897887
[No Abstract] [Full Text] [Related]
14. 3,4,4'-Trihydroxy-trans-stilbene, an analogue of resveratrol, is a potent antioxidant and cytotoxic agent.
Cai W; Zhang L; Song Y; Zhang B; Cui X; Hu G; Fang J
Free Radic Res; 2011 Nov; 45(11-12):1379-87. PubMed ID: 21974738
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of resveratrol.
Campagna M; Rivas C
Biochem Soc Trans; 2010 Feb; 38(Pt 1):50-3. PubMed ID: 20074034
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of trans-resveratrol and its analogues.
Ovesná Z; Horváthová-Kozics K
Neoplasma; 2005; 52(6):450-5. PubMed ID: 16284688
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
Lim KG; Gray AI; Anthony NG; Mackay SP; Pyne S; Pyne NJ
Arch Toxicol; 2014 Dec; 88(12):2213-32. PubMed ID: 25344023
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol and derivatives for the prevention and treatment of cancer.
Fulda S
Drug Discov Today; 2010 Sep; 15(17-18):757-65. PubMed ID: 20692359
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol and its analogues: promising antitumor agents.
Huang X; Zhu HL
Anticancer Agents Med Chem; 2011 Jun; 11(5):479-90. PubMed ID: 21524243
[TBL] [Abstract][Full Text] [Related]
20. A DFT method for the study of the antioxidant action mechanism of resveratrol derivatives.
Benayahoum A; Amira-Guebailia H; Houache O
J Mol Model; 2013 Jun; 19(6):2285-98. PubMed ID: 23377959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
